Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Leverage Shares 3x Long Moderna (MRNA) ETP Securities, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) has returned 171.41% so far this year and 26.11% over the past 12 months.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities
- 1D
- 3.64%
- 1M
- -25.96%
- YTD
- 171.41%
- 6M
- 252.24%
- 1Y
- 26.11%
- 3Y*
- -92.70%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Dec 15, 2021, MRN3.L's average daily return is -0.26%, while the average monthly return is -9.14%.
Historically, 37% of months were positive and 63% were negative. The best month was Jan 2026 with a return of +152.5%, while the worst month was Aug 2024 at -80.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 12 months.
On a daily basis, MRN3.L closed higher 45% of trading days. The best single day was Feb 3, 2022 with a return of +113.6%, while the worst single day was Jan 13, 2025 at -70.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 152.49% | 45.18% | -25.96% | 171.41% | |||||||||
| 2025 | -40.89% | -63.44% | -36.96% | -14.36% | -29.55% | 17.00% | 16.70% | -56.53% | 0.00% | 19.03% | -27.18% | 49.73% | -93.67% |
| 2024 | 1.27% | -30.31% | 34.59% | 11.55% | 90.68% | -51.15% | -0.66% | -80.90% | -49.06% | -49.96% | -55.15% | -30.56% | -98.51% |
| 2023 | 0.65% | -59.72% | 17.46% | -35.04% | -18.01% | -10.19% | -14.73% | -15.53% | -40.18% | -61.41% | 4.04% | 83.69% | -92.76% |
| 2022 | -75.70% | -29.90% | 21.11% | -50.27% | -9.21% | -19.56% | 37.54% | -49.88% | -40.53% | 98.28% | 43.86% | -11.08% | -92.21% |
| 2021 | -36.68% | -36.68% |
Benchmark Metrics
Leverage Shares 3x Long Moderna (MRNA) ETP Securities has an annualized alpha of -50.89%, beta of 1.91, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since December 16, 2021.
- This ETF participated in 276.89% of S&P 500 Index downside but only -228.41% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.02 means this ETF moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -50.89%
- Beta
- 1.91
- R²
- 0.02
- Upside Capture
- -228.41%
- Downside Capture
- 276.89%
Expense Ratio
MRN3.L has an expense ratio of 0.75%, placing it in the medium range.
Return for Risk
Risk / Return Rank
MRN3.L ranks 34 for risk / return — below 34% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) and compare them to a chosen benchmark (S&P 500 Index).
| MRN3.L | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.12 | 0.90 | -0.77 |
Sortino ratioReturn per unit of downside risk | 1.86 | 1.39 | +0.47 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.21 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | 0.22 | 1.40 | -1.18 |
Martin ratioReturn relative to average drawdown | 0.35 | 6.61 | -6.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore MRN3.L risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Leverage Shares 3x Long Moderna (MRNA) ETP Securities. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Leverage Shares 3x Long Moderna (MRNA) ETP Securities was 100.00%, occurring on Nov 21, 2025. The portfolio has not yet recovered.
The current Leverage Shares 3x Long Moderna (MRNA) ETP Securities drawdown is 100.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Dec 21, 2021 | 826 | Nov 21, 2025 | — | — | — |
| -0.32% | Dec 16, 2021 | 1 | Dec 16, 2021 | 1 | Dec 20, 2021 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...